Skip to main content
Intrasense logo

Intrasense — Investor Relations & Filings

Ticker · ALINS ISIN · FR0011179886 LEI · 969500VF6MOVQXWHAE33 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2013-12-03 Regulatory Filings
Country FR France
Listing PA ALINS

About Intrasense

https://www.intrasense.fr/

Intrasense, a subsidiary of the Guerbet Group, is a medical technology company that develops and markets advanced software solutions for medical imaging. Its flagship product, the Myrian® platform, is a comprehensive visualization tool that assists healthcare professionals in reviewing and analyzing 2D and 3D medical images from modalities such as MRI and CT scanners. The company's solutions are characterized by the native integration of Artificial Intelligence (AI) algorithms to enhance diagnostic accuracy and workflow efficiency. Intrasense also offers specialized solutions, including Liflow® for oncology imaging and the DUOnco™ suite of AI tools for lesion detection. The technology aims to facilitate and secure clinical diagnosis, decision-making, and therapeutic monitoring for radiologists and other clinicians.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document announces a significant business event: the signing of a global OEM agreement between Intrasense and Cerner for the integration of Intrasense's Myrian® solution into Cerner's PACS offering. This type of announcement, detailing a strategic partnership, acquisition, or major commercial deal, most closely aligns with the 'M&A Activity' category (TAR) if it were a merger/takeover, but since it is a strategic partnership/OEM agreement, it falls under the broader category of significant corporate transactions or strategic updates. Given the provided definitions, none perfectly capture a standard strategic partnership announcement. However, 'M&A Activity (TAR)' is often used broadly for major corporate transactions. If we strictly adhere to the definitions, this is not a merger or takeover (TAR). It is not an earnings release (ER), capital change (CAP), or director dealing (DIRS). Since it is a major corporate announcement that doesn't fit the specific financial reporting codes (10-K, IR, ER, etc.), the most appropriate fallback category is 'Regulatory Filings' (RNS) as a general corporate announcement, or potentially 'Capital/Financing Update' (CAP) if the partnership is viewed as a major commercialization/distribution agreement, but TAR is usually reserved for M&A. Given the context of a major commercial agreement, and lacking a specific 'Strategic Partnership' code, I will classify it as a general Regulatory Filing (RNS) as it is a material, non-standard announcement, or consider if it implies a major change in business structure. Since it is a press release announcing a major commercial deal, and not a formal regulatory filing like a 10-K or a specific financial report, RNS (Regulatory Filings/General Announcement) is the safest fallback. If a 'Strategic Partnership' code existed, it would be preferred. Based on the provided list, RNS is the best fit for a material press release that isn't explicitly covered elsewhere.
2013-12-03 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 95% confidence The document is a press release dated November 19, 2013, announcing a new business contract where Intrasense's software (Myrian®) will be used by Micron Inc. (a Japanese imaging CRO) in an MRI imaging trial. This type of announcement, detailing a specific business development, contract win, or partnership, does not fit the definitions for standard financial reports (10-K, IR, ER, MRQ) or specific corporate actions (DIV, SHA, POS). It is a general corporate announcement. Since it is not a formal regulatory filing like an 8-K (which is not an option) and is more specific than a general 'Regulatory Filing' (RNS), I must evaluate the closest fit. It is not a management change (MANG), a legal update (LTR), or a financing event (CAP). Given the options, this is best classified as a general corporate update that doesn't fit the highly specific financial reporting categories. Therefore, the fallback category 'Regulatory Filings' (RNS) is the most appropriate choice for a general, non-standardized corporate news release that doesn't match the other specific types.
2013-11-19 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated November 19, 2013, announcing a business agreement between Intrasense and Micron Inc. (a Japanese imaging CRO) regarding the use of Intrasense's Myrian® software in an MRI clinical study. This type of announcement, detailing a specific business development, partnership, or contract win, does not fit neatly into the defined categories like 10-K (Annual Report), ER (Earnings Release), or CT (Call Transcript). It is a general corporate announcement regarding business operations and strategy, which often falls under miscellaneous regulatory filings or investor relations updates. Since there is no specific category for 'Business Development Announcement' or 'Partnership,' and it is not a formal financial report, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for corporate news releases that don't match other specific types.
2013-11-19 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
M&A Activity Classification · 99% confidence The document announces a strategic business development: an OEM agreement between Intrasense and IMAGE Information Systems regarding medical imaging software integration. It details the partnership, product integration (IQ-VIEW PRO 4D), and includes quotes from CEOs. This type of announcement, focusing on a significant business transaction or partnership that impacts future operations or market position, does not fit neatly into standard financial reporting categories like 10-K, ER, or IR. It is a general corporate announcement regarding business strategy and partnerships. Since it is not a specific filing type (like M&A, Capital Change, or Director Dealing), and it is a substantive announcement rather than just a notice of publication, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for significant corporate news that doesn't fit elsewhere, especially when the text reads like a press release.
2013-11-12 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated November 12, 2013, announcing a strategic OEM contract between Intrasense and IMAGE Information Systems for integrating Myrian® software into IMAGE's PACS offering. This type of announcement, detailing a significant business partnership or contract signing, does not fit the specific financial reporting categories (10-K, IR, ER, etc.). It is a general corporate announcement regarding business development. Since it is not a management change (MANG), financing event (CAP), or legal matter (LTR), the most appropriate general category for significant corporate news that doesn't fit elsewhere is Regulatory Filings (RNS), which serves as a broad category for miscellaneous official announcements.
2013-11-12 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated October 14, 2013, announcing the launch of a new software module (Myrian® XP-Prostate) for MRI exams related to prostate cancer, to be presented at the JFR 2013 event. It details product features, market context, and company updates, including other module releases and contact information for investors. This type of announcement, focusing on a new product launch, strategic update, or general corporate news that doesn't fit specific financial reporting categories (like 10-K, ER, or DIV), is best classified as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were structured as slides. Given the format is a news release announcing a product and event participation, and it doesn't fit the specific definitions for M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), RNS serves as the most appropriate general regulatory announcement category. It is not a formal financial report (10-K, IR, ER, MRQ).
2013-10-14 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.